Leeching in the history - a review
Historical review published in Pak J Biol Sci (2008)
Abstract
Leeching has enjoyed a good reputation in the past where it had been used in various ailments from fevers to flatulence. The present day scientists have limited its role and the leeching nowadays is being used only in microsurgeries to relieve the venous congestion. This study was designed to explore the possibility of revival of the leech therapy (leeching) which is still being used traditionally as therapeutic agent in various ailments. Leeching is not the outcome of the medieval period but has been in use during the times when there was no concept of the disease and medicament. The earliest clearly documented record of leeches being used for remedial purpose appears in a painting in an Egyptian Tomb of around 1500 BC. The journey of the leech therapy reached its zenith in 17th and 18th century AD in Europe while as during the Arab era the leeches were used medicinally but only for the bloodletting. During the 17th and 18th century AD there was shortage of leeches in certain European countries due to its rigorous use. During early 20th century AD when germ theory was put forward and medical fraternity believed that every disease has its origin from germs and the era of antibacterial therapy gained a pace, the leech therapy was considered the myth of the past. It was in 1970's that the leech therapy was revived by only limited to the microsurgeries to relieve venous congestions. During the 21st century there were certain studies when the leeches were tried in certain ailments like arthritis etc. and the Food and Drug Authority of USA (FDA) gave permission for sale and use of leeches in USA but limited its use in microsurgeries and plastic surgeries only. The aim of this study was to explore different diseases where the role of leech therapy can be seen and clinical trials can be started in this direction. Although the researchers in Regional Research Institute of Unani Medicine, Srinagar, Kashmir, India working under the aegis of Central Council for Research in Unani Medicine started the clinical trials for leech therapy in frost bite way back in 1999, but there are certain unexplored areas where leech therapy can prove beneficial and need is to take up the studies on other disease on larger sample size.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
Comprehensive historical review of leech therapy from the Egyptian Tomb painting (~1500 BC), the 17-18th century European peak, the 20th-century decline with antibiotics, and the 1970s revival in microsurgery. Documents FDA permission for sale and use of leeches.
Warum dies für die Hirudotherapie relevant ist
Dieser historische Übersichtsartikel zeichnet die Verwendung der Blutegeltherapie vom alten Ägypten über ihren Höhepunkt im 17. und 18. Jahrhundert in Europa, ihren Niedergang mit dem Aufkommen der Keimtheorie bis hin zu ihrer modernen Wiederbelebung in der Mikrochirurgie zur Linderung venöser Stauung nach. Für den ASH-Bereich ist er relevant, da er für die Erforschung der Blutegeltherapie in bislang unerschlossenen Bereichen wie Arthritis plädiert und dabei laufende klinische Studien zu Frostbeulen sowie die FDA-Zulassung für plastische und mikrochirurgische Eingriffe hervorhebt. Der Artikel unterstreicht die anhaltende Relevanz und das potenzielle Erweiterungspotenzial des Blutegelns in der modernen Medizin. Als historischer Übersichtsartikel präsentiert er keine originären klinischen Daten und quantifiziert nicht die Wirksamkeit der Blutegeltherapie bei einer spezifischen modernen Erkrankung, sondern fordert vielmehr klinische Studien in größerem Maßstab in neuen therapeutischen Anwendungsbereichen.
Zitation
Leeching in the history - a review.
Munshi Y et al. · Pakistan journal of biological sciences, 2008
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: 18. Juni 2026